Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SARS-CoV-2 Mpro inhibitors(SARS-CoV-2 main protease inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H11ClN2O2 |
InChIKeyJROSKNTUYSPHGX-UHFFFAOYSA-N |
CAS Registry2835511-03-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | JP | 28 Jan 2021 |